Names: Brook Byers and Beth Seidenberg
Organisation: Kleiner Perkins Caufield & Byers
Positions: Founding member and general partner
Kleiner Perkins Caufield & Byers (KPCB) has invested in and helped build more than 100 life sciences companies that have developed products to treat underserved medical needs.
Brook Byers is the founding member of KPCB and president of four biotechnology companies that were developed in KPCB’s offices. All four went on to become public companies with an aggregate market value of more than $8 billion.
Beth Seidenberg is a general partner at KPCB and focuses on life sciences and investing in digital health and biotech companies. She works with entrepreneurs to develop companies with breakthrough technology for treating patients and improving the delivery of healthcare.